Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)
Richard Quinn is an award-winning journalist with 15 years’ experience. He has worked at the Asbury Park Press in N.J. and The Virginian-Pilot in Norfolk, Va., and currently is managing editor for a leading commercial real estate publication. His freelance work has appeared in The Jewish State, The Hospitalist, The Rheumatologist, ACEP Now and ENT Today. He lives in New Jersey with his wife, new son and three cats.
Articles by Richard Quinn
2013 ACR/ARHP Annual Meeting: Health Professionals In the Spotlight
ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology
Joint Smart Coalition Takes on Psoriasis in New York City
The Arthritis Foundation and the National Psoriasis Foundation launched the Joint Smart Coalition to focus on patient education, resources, and outreach. At a coalition-sponsored community-outreach event at Queens College in Flushing, N.Y., attendees were provided information on setting goals, stretching techniques, easy exercises, treatment options, and tips for a healthy lifestyle. (posted Dec. 13)
2013 ACR/ARHP Annual Meeting: Rheumatologists In the Spotlight
ACR members honored with awards for service, research, and mentorship in rheumatology
The American College of Rheumatology Helps Keep Three Biologics Off the SAD List
In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage. (posted Nov. 19)
Survey Highlights High Out-of-pocket Costs for RA Care
The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at $1,000 to $5,000 per year. (posted Oct. 25)
Medicare Participation Numbers Don’t Tell the Whole Story
Although HHS reports no significant changes in Medicare participation for office-based physicians, the numbers may be misleading. (posted Oct. 16, 2013)
Supreme Court Decision on Gene Patents Good News for Clinicians, Researchers
The recent U.S. Supreme Court decision that ruled human genes cannot be patented may provide greater access to genetic testing. (posted Sept. 24, 2013)
SGR Fix Finally on the Horizon?
By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
RA Treatment Options Expanded with New Infusible TNF Inhibitor
FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)